News - Sartorius BIA Separations

Your inquiry cart is empty.

On May 12th, the biaseparations.com website will be retired and migrated tosartorius.com.Learn moreabout our combined offering today!

15Mar2023

Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development

2Feb2023

Sartorius BIA Separations and Arnav Biotech enter in collaboration to develop a mRNA synthesis and purification platform, supported with PATfix in-process analytical solution

22Nov2022

Sartorius BIA Separations and Exopharm sign joint research agreement to develop integrated technology for large-scale exosome production

25Oct2022

Downstream AAV Production: A Targeted Approach to improve Empty / Full capsid separation (a Case Study with Pharmaron)

22Jun2022

New Achievement: The best performing company in Slovenia

22Jun2022

Thank you for attending Monolith Summer Symposium!

1Apr2022

BIA Separations (Sartorius) is now part of new EIC Pathfinder project Yscript

3Nov2021

BioNet and Sartorius’ company BIA Separations collaborate on production process development of mRNA vaccines

29Jun2021

Introduction of speCIMen

22Mar2021

Sartorius Creates a Premium Gene Therapy and Vaccine Portfolio With the Acquisition of BIA Separations

22Mar2021

BIA Separations to supply columns for mRNA purification

28Jan2021

BIA Separations welcomes a new specialized expert to the team